Male Contraception Initiative works with researchers across the globe to make male contraceptive options a reality.
Here's some of what's possible.
Epic win for male contraception development: Daré Bioscience, a clinical-stage women’s biopharmaceutical company recently entered an agreement to purchase the intellectual property around CatSper. CatSper is a sperm ion channel essential for fertilization and has been identified as a possible target for male contraceptive development. The agreement transfers assets from Hydra Biosciences, which was co-founded by […]
MCI attended the BROMO Conference on Natural Products at Airlangga University in Indonesia, and met with the research team behind Gendarussa, a natural plant extraction being tested as a male contraceptive. Gendarussa was originally used by native peoples in the Indonesian province of Papua as a contraceptive. Ethnographers discovered that users of Gendarussa would make a […]
NIH Funding Op: Male Contraceptive Research The National Institutes of Health (NIH) announced a funding opportunity directed towards early stage research on innovative, non-steroidal methods of contraception, including male contraceptive methods. The deadline for a Letter of Intent (LOI) is October 6th, 2018. The full announcement details a phased funding mechanism, which offers support for […]
Clinicians and scientists involved with the hormonal male contraceptive Nestorone/Testosterone (NEST) clinical trials hosted a Reddit Ask Me Anything (AMA) conversation. Reddit users asked questions about the development, use, and acceptability of the hormonal male contraceptive Nestorone/Testosterone (NEST). The thread attracted over 1600 comments and questions that ranged from in-depth scientific considerations of endocrinology to […]
Research Update on Male Contraception The American Society of Andrology 2018 annual meeting in Portland, Oregon included a one-day symposium on male contraception research, hosted by MCI Acting Board Vice Chair Mitch Eddy. Researchers used the opportunity to connect and collaborate and highlight the demand for and status of male contraceptives globally. The Speakers A […]
Hormonal contraceptives for men have seen a lot of attention lately A new study released at the Endocrine Society Meeting announced the success of an early-stage clinical trial of a male hormonal contraceptive option called dimethandrolone undecanoate. Concurrently, there’s a larger trial recruiting male participants for a topical gel, aiming to enroll 400 couples to […]
MALE CONTRACEPTION INITIATIVE AWARDS $600k IN RESEARCH GRANTS FOR THE DEVELOPMENT OF NEW MALE CONTRACEPTIVE PRODUCTS Development collaborations include University of Minnesota, University of Nevada, National Research Council in Argentina and Monash University in Australia DURHAM, NC – Male Contraception Initiative (MCI), a private non-profit foundation, announces the award of four grants totalling $600,000 […]
Funding Opportunity for Innovative Male Contraception Research The National Institutes of Health (NIH) announced a new funding effort to further innovation in contraception – and it includes male methods. DEADLINE: April 16th, 2018. The full announcement, with plans to commit $1.5 Million in 2018 for a maximum of 6 awards, can be found on the […]
It’s time for male contraception. Current contraception options available for men are falling short. Vasectomies are perceived as an irreversible method, and the real-world pregnancy rate for the condom is 13% —a truly high number if you’re looking for a fail-safe birth control method. Better contraceptive options for men will bring equity to family planning, […]
It may seem hard to start a conversation about contraception. But when conversation lags, we’ll be happy to help you out with three good ways to bring up a topic sure to liven up the discussion. 1 – Set embarrassment aside. There’s no need to be embarrassed. Contraception is a normal topic in today’s world. […]
Want free content or to reference our stuff? Just link to the page you'd like to use and reference "Male Contraception Initiative." There's no need to ask, but if you shoot us an e-mail, we may be able to share your page!